Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06001918 · ClinicalTrials.gov registry record · Phase 2

Nectero EAST System Clinical Study

A Phase 2 study of Abdominal Aortic Aneurysm, sponsored by Nectero Medical.

Recruiting
Registry status
Phase 2
Development phase
400
Enrollment target
20
Study locations

NCT06001918 is a Phase 2 study of Abdominal Aortic Aneurysm that is actively recruiting participants, run by Nectero Medical. The registered enrollment target is 400 participants, roughly in line with the 429-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target. The trial reports 20 study locations across 15 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06001918, a Phase 2 study of Abdominal Aortic Aneurysm, is actively recruiting participants, sponsored by Nectero Medical.

RECRUITING
Registry status
Phase 2
Development phase
400 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.

Conditions Studied

Abdominal Aortic Aneurysm

Interventions

  • DRUG Nectero EAST System

Study Locations (20)

Massachusetts

  • Massachusetts General Hospital - Boston
  • Beth Israel Deaconess Medical Center - Boston
  • University of Massachusetts - Worcester

Ohio

  • The Christ Hospital - Cincinnati
  • University Hospitals Cleveland - Cleveland
  • Cleveland Clinic - Cleveland

New York

  • University of Rochester - Rochester
  • Stony Brook Medicine - Stony Brook

Arizona

  • Honor Health Scottsdale Shea Medical Center - Scottsdale

Colorado

  • University of Colorado - Aurora

District of Columbia

  • Medstar Washington Hospital Center - Washington D.C.

Florida

  • Prime Vascular Institute - Delray Beach

Georgia

  • Medical College of Georgia - Augusta

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-10-25
Est. Completion 2029-12-31
Phase Phase 2

Sponsor

Nectero Medical

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06001918

The ClinicalTrials.gov registry entry for NCT06001918 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 429-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target. The listed sponsor is Nectero Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Nectero EAST System is the first listed.

NCT06001918 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Massachusetts, Ohio, New York.

Frequently Asked Questions

What is clinical trial NCT06001918 about?

NCT06001918 is a clinical study titled "Nectero EAST System Clinical Study". The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of t...

What is the current status of trial NCT06001918?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 400 participants. The study started on 2023-10-25. Estimated completion is 2029-12-31.

What conditions does trial NCT06001918 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.

What interventions are being tested in trial NCT06001918?

The interventions under investigation include: Nectero EAST System (DRUG).

Who is sponsoring clinical trial NCT06001918?

This trial is sponsored by Nectero Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06001918 being conducted?

This trial has 20 study locations across Arizona, Colorado, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Abdominal Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Abdominal Aortic Aneurysm

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.